3,491
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Knowledge and awareness of Human Papillomavirus (HPV) and HPV vaccines among Caribbean youth: the case of the Bahamas

ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 573-580 | Received 23 Apr 2019, Accepted 18 Aug 2019, Published online: 23 Sep 2019

References

  • Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. JNCI J National Cancer Inst. 2015;107(6):djv086. doi:10.1093/jnci/djv086.
  • Phillips AA, Jacobson JS, Magai C, Consedine N, Horowicz-Mehler NC, Neugut AI. Cancer incidence and mortality in the Caribbean. Cancer Invest. 2007;25(6):476–83. doi:10.1080/07357900701359841.
  • Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M Human papillomavirus–associated cancers—United States, 2008–2012. MMWR. Morbidity and Mortality Weekly Report 2016:65 doi:10.15585/mmwr.mm6526a1
  • Colón-López V, Ortiz AP, Soto-Salgado M, Torres-Cintrón M, Mercado-Acosta JJ, Suárez E. Anal cancer incidence and mortality in Puerto Rico. P R Health Sci J. 2013;32:76–81.
  • Walsh T, Bertozzi-Villa C, Schneider JA. Systematic review of racial disparities in human papillomavirus–associated anal dysplasia and anal cancer among men who have sex with men. Am J Public Health. 2015;105(4):e34–e45. doi:10.2105/AJPH.2014.302469.
  • Nyitray AG, Fujimoto K, Zhao J, Giuliano AR, Schneider JA, Hwang L-Y. Prevalence of and risk factors for anal human papillomavirus infection in a sample of young, predominantly black men who have sex with men, Houston, Texas. J Infect Dis. 2018;217(5):777–84. doi:10.1093/infdis/jix617.
  • Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L. Immunization services division NCfI, Respiratory diseases CDC et al. Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014–united states. MMWR. Morb. Mortal. Wkly. Rep. 2014;63:620–24.
  • McQuillan GM, Kruszon-Moran D, Markowitz LE, Unger ER, Paulose-Ram R. Prevalence of HPV in adults aged 18-69: United States. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics Hyattsville, MD:National Center for Health Statistics. [Accessed 2018 July 25]2011–2014.
  • de Pokomandy A, Rouleau D, Ghattas G, Vezina S, Cote P, Macleod J, Allaire G, Franco Eduardo L, Coutle F. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV infected men: the hipvirg cohort study. J Infect Dis. 2009;199(7):965–73. doi:10.1086/597207.
  • de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56. doi:10.1016/S1470-2045(10)70230-8.
  • Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 2010;117(2 Suppl):S5–10. doi:10.1016/j.ygyno.2010.01.024.
  • Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Gomez D, Bosch FX, de Santos S, Mena M, Muñoz J. Human papillomavirus and related diseases report: Bahamas. In: Human papillomavirus and related diseases report: Bahamas. ICO/IARC HPV Information Centre; 2017. July 27, [Accessed 2018 February 25].
  • Louie KS, de Sanjose S, Diaz M, Castellsagué X, Herrero R, Meijer CJ, Shah K, Franceschi S, Muñoz N, Bosch FX. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer. 2009;100(7):1191–97. doi:10.1038/sj.bjc.6604974.
  • Chen H-C, Schiffman M, Lin C-Y, Pan M-H, You S-L, Chuang L-C, Hsieh C-Y, Liaw K-L, Hsing AW, Chen C-J, et al. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst. 2011;103(18):1387–96. doi:10.1093/jnci/djr283.
  • Liu Z-C, Liu W-D, Liu Y-H, Ye X-H, Chen S-D. Multiple sexual partners as a potential independent risk factor for cervical cancer: a meta-analysis of epidemiological studies. Asian Pac J Cancer Prev. 2015;16(9):3893–900. doi:10.7314/apjcp.2015.16.9.3893.
  • Li S, Ni XB, Xu C, Wang XH, Zhang C, Zeng XT. Oral sex and risk of oral cancer: a meta-analysis of observational studies. J Evid Based Med. 2015;8(3):126–33. doi:10.1111/jebm.12159.
  • Antonsson A, Cornford M, Perry S, Davis M, Dunne MP, Whiteman DC. Prevalence and risk factors for oral HPV infection in young Australians. PLoS One. 2014;9(3):e91761. doi:10.1371/journal.pone.0091761.
  • Lewis-Bell K Lessons learned from HPV introduction in the Caribbean. In. https://www.sabin.org/sites/sabin.org/files/karen_lewins.pdf. [Accessed 2019 March 4].
  • Maura M. Government to tackle cervical cancer through introduction of HPV vaccine. In: Govt. To tackle cervical cancer through introduction of HPV vaccine. Nassau (Bahamas); 2013. July 4. [Accessed  2018 July 26].https://www.Eleutheranews.com
  • Halliday D, Butler R, Francis D, Thompson J, Joseph M, Ragin C. Knowledge and attitudes toward HPV and the HPV vaccines in The Bahamas. West Indian Med J. 2013;62(8):(731–737).doi: 10.7727/wimj.2012.318
  • SJ MH K, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546–56. doi:10.1016/j.vaccine.2012.03.063.
  • Bird Y, Obidiya O, Mahmood R, Nwankwo C, Moraros J. Human papillomavirus vaccination uptake in Canada: a systematic review and meta-analysis. Int J Prev Med. 2017;8(71). doi:10.4103/ijpvm.IJPVM_324_16.
  • Loke AY, Kwan ML, Wong YT, Wong AKY. The uptake of human papillomavirus vaccination and its associated factors among adolescents: a systematic review. J Prim Care Community Health. 2017;8(4):349–62. doi:10.1177/2150131917742299.
  • Deveaux L, Lunn S, Mae Bain R, Gomez P, Kelly T, Brathwaite N, Russell-Rolle G, Li X, Stanton B. Focus on youth in the Caribbean: beyond the numbers. J Int Assoc Physicians AIDS Care. 2011;10(5):316–25. (Chicago, Ill.: 2002). doi:10.1177/1545109710397367.
  • Waller J, Ostini R, Marlow LAV, McCaffery K, Zimet G. Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory. Prev Med. 2013;56(1):35–40. doi:10.1016/j.ypmed.2012.10.028.
  • Marlow LAV, Zimet GD, McCaffery KJ, Ostini R, Waller J. Knowledge of human papillomavirus (HPV) and HPV vaccination: an international comparison. Vaccine. 2013;31(5):763–69. doi:10.1016/j.vaccine.2012.11.083.
  • Farsi NJ, El-Zein M, Gaied H, Lee YCA, Hashibe M, Nicolau B, Rousseau MC. Sexual behaviours and head and neck cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2015;39(6):1036–46. doi:10.1016/j.canep.2015.08.010.
  • D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944–56. doi:10.1056/NEJMoa065497.
  • Stock ML, Peterson LM, Houlihan AE, Walsh LA. Influence of oral sex and oral cancer information on young adults’ oral sexual-risk cognitions and likelihood of HPV vaccination. J Sex Res. 2013;50(1):95–102. doi:10.1080/00224499.2011.642904.
  • Forster A, Wardle J, Stephenson J, Waller J. Passport to promiscuity or lifesaver: press coverage of HPV vaccination and risky sexual behavior. J Health Commun. 2010;15(2):205–17. doi:10.1080/10810730903528066.
  • Pitts MK, Dyson SJ, Rosenthal DA, Garland SM. Knowledge and awareness of human papillomavirus (HPV): attitudes towards HPV vaccination among a representative sample of women in Victoria, Australia. Sex Health. 2007;4:177–80.
  • Xue L, Hu W, Zhang H, Xie Z, Zhang X, Zhao F, Qiao Y, Gao L, Ma W. Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China. Hum Vaccin Immunother. 2018;14(2):404–11. doi:10.1080/21645515.2017.1393132.
  • Patel H, Jeve YB, Sherman SM, Moss EL. Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: A systematic review. Sex Transm Infect. 2016;92(6):474–79. doi:10.1136/sextrans-2015-052341.
  • Forster AS, Marlow LAV, Wardle J, Stephenson J, Waller J. Interest in having HPV vaccination among adolescent boys in England. Vaccine. 2012;30(30):4505–10. doi:10.1016/j.vaccine.2012.04.066.
  • FDA licensure of quadrivalent human papillomavirus vaccine (HPV4. Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). JAMA. 2010;304(5):518–19.
  • Daley EM, Vamos CA, Thompson EL, Zimet GD, Rosberger Z, Merrell L, Kline NS. The feminization of HPV: how science, politics, economics and gender norms shaped U.S. HPV vaccine implementation. Papillomavirus Res. 2017;3(142–148). doi:10.1016/j.pvr.2017.04.004.
  • Fontenot HB, Collins Fantasia H, Charyk A, Sutherland MA. Human papillomavirus (HPV) risk factors, vaccination patterns, and vaccine perceptions among a sample of male college students. J Am Coll Health. 2014;62(3):186–92. doi:10.1080/07448481.2013.872649.
  • Patty NJS, van Dijk HM, Wallenburg I, Bal R, Helmerhorst TJM, van Exel J, Cramm JM. To vaccinate or not to vaccinate? Perspectives on HPV vaccination among girls, boys, and parents in the Netherlands: A q-methodological study. BMC Public Health. 2017;17(1):872. doi:10.1186/s12889-017-4879-2.
  • Houlihan CF, Larke NL, Watson-Jones D, Smith-McCune KK, Shiboski S, Gravitt PE, Smith JS, Kuhn L, Wang C, Hayes R. Human papillomavirus infection and increased risk of HIV acquisition. Syst Rev Meta-anal AIDS. 2012;26:2211–22.
  • Looker KJ, Rönn MM, Brock PM, Brisson M, Drolet M, Mayaud P, Boily MC. Evidence of synergistic relationships between hiv and human papillomavirus (HPV): systematic reviews and meta analyses of longitudinal studies of HPV acquisition and clearance by hiv status, and of hiv acquisition by HPV status. J Int AIDS Soc. 2018;21(6):e25110. doi:10.1002/jia2.25110.
  • Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among us adolescents: A systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82. doi:10.1001/jamapediatrics.2013.2752.
  • Batista Ferrer H, Trotter CL, Hickman M, Audrey S. Barriers and facilitators to uptake of the school-based HPV vaccination programme in an ethnically diverse group of young women. J Public Health (Oxf). 2016;38(3):569–77. doi:10.1093/pubmed/fdv073.
  • Brisson M, É B, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily M-C, Smith MA, Berkhof J, et al. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: A systematic review and meta-analysis of predictions from transmission-dynamic models. Lancet Publ Health. 2016;1(1):e8–e17. doi:10.1016/S2468-2667(16)30001-9.
  • Cunningham MS, Davison C, Aronson KJ. HPV vaccine acceptability in Africa: A systematic review. Prev Med. 2014;69(274–279). doi:10.1016/j.ypmed.2014.08.035.
  • Dempsey AF, Butchart A, Singer D, Clark S, Davis M. Factors associated with parental intentions for male human papillomavirus vaccination: results of a national survey. Sex Transm Dis. 2011;38(8):769–76. 710.1097/OLQ.1090b1013e318211c318248. doi:10.1097/OLQ.0b013e318211c248.
  • Fiks AG, Grundmeier RW, Mayne S, Song L, Feemster K, Karavite D, Hughes CC, Massey J, Keren R, Bell LM, et al. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics. 2013;131(6):1114–24. doi:10.1542/peds.2012-3122.
  • Santelli J, Ott MA, Lyon M, Rogers J, Summers D, Schleifer R. Abstinence and abstinence-only education: A review of u.S. policies and programs. J Adolesc Health. 2006;38(1):72–81. doi:10.1016/j.jadohealth.2005.10.006.
  • Perkins EL, Stennis KB, Taylor Spriggs V, Kwegyir-Afful EA, Prather A. Is knowledge enough? Considering hiv/aids risk behaviors and hiv/aids knowledge with African American women. Int. J. High. Risk. Behav. Addict. 2014;3(3):e15038–e15038. doi:10.5812/ijhrba.15038.